Matches in Wikidata for { <http://www.wikidata.org/entity/Q91240775> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91240775 description "article scientifique publié en 2017" @default.
- Q91240775 description "artículu científicu espublizáu n'avientu de 2017" @default.
- Q91240775 description "im Dezember 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91240775 description "scientific article published on 08 December 2017" @default.
- Q91240775 description "wetenschappelijk artikel" @default.
- Q91240775 description "наукова стаття, опублікована в грудні 2017" @default.
- Q91240775 name "Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication" @default.
- Q91240775 name "Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication" @default.
- Q91240775 type Item @default.
- Q91240775 label "Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication" @default.
- Q91240775 label "Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication" @default.
- Q91240775 prefLabel "Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication" @default.
- Q91240775 prefLabel "Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication" @default.
- Q91240775 P1433 Q91240775-AB9D3827-EFC8-43CD-B9C0-04AF6D4EDBFC @default.
- Q91240775 P1476 Q91240775-2CB2B158-F186-41D2-AD5C-40AC9A839224 @default.
- Q91240775 P2093 Q91240775-134026AA-C5C6-48C3-9477-EE7350ABE3DF @default.
- Q91240775 P2093 Q91240775-C2D1996A-6319-4C59-8146-85FBA0507BC1 @default.
- Q91240775 P2093 Q91240775-D1F20E97-A685-47C0-8FBD-DF605001411A @default.
- Q91240775 P304 Q91240775-6673E08F-DAFE-402B-982C-BC43B1E2386D @default.
- Q91240775 P31 Q91240775-A44003DE-8EB0-4D25-8965-C63DEBB72105 @default.
- Q91240775 P356 Q91240775-63BA759B-0481-442B-A980-9333FE9F9CC9 @default.
- Q91240775 P433 Q91240775-F4E2AB62-50F7-44BC-88D9-DF638992328C @default.
- Q91240775 P478 Q91240775-34D314A7-78E3-4028-AA9B-3C9B37B1A493 @default.
- Q91240775 P577 Q91240775-3481C7FE-BAE9-47BD-AFDA-70841ECCB503 @default.
- Q91240775 P698 Q91240775-90B46819-0BED-4CE9-864E-1E1575122906 @default.
- Q91240775 P932 Q91240775-EA137ABB-16D6-4F43-8EAB-E3A8FC5642BE @default.
- Q91240775 P356 J.JSPS.2017.12.005 @default.
- Q91240775 P698 30166922 @default.
- Q91240775 P1433 Q15763912 @default.
- Q91240775 P1476 "Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication" @default.
- Q91240775 P2093 "Bander Balkhi" @default.
- Q91240775 P2093 "Enrique Seoane-Vazquez" @default.
- Q91240775 P2093 "Rosa Rodriguez-Monguio" @default.
- Q91240775 P304 "238-243" @default.
- Q91240775 P31 Q13442814 @default.
- Q91240775 P356 "10.1016/J.JSPS.2017.12.005" @default.
- Q91240775 P433 "2" @default.
- Q91240775 P478 "26" @default.
- Q91240775 P577 "2017-12-08T00:00:00Z" @default.
- Q91240775 P698 "30166922" @default.
- Q91240775 P932 "6111194" @default.